Background: In-hospital mortality in female patients with acute myocardial infarction (AMI) and factors affecting this may be different from those of their male counterpart. The aim of the current study was to compare the in-hospital mortality between female and male patients with AMI and to compare the differences in age, risk factors, treatment given and complications between them. Methods: Total 200 nonrandomised patients with a definite diagnosis of AMI admittedover a period of one year (January 2008 -December 2008) were enrolled in the study, in which 100 female patients were considered as cases and 100 male patients as controls. Both groups were studied prospectively.Datawere collected in prefixed questionnaire and data sheet and were analysed using SPSS software.
In Bangladesh, in a 3 month follow up study after AMI, mortality was 36.3% in females compared to 19.4% in males 3 . But factors influencing increased in-hospital and short-term mortality in females have not been studied in Bangladesh. Finding out the influencing factors of mortality is important for the development of appropriate measures to improve their clinical course and outcome. If these influencing factors could be managed earlier and properly, many female lives could be saved by taking effective measures and higher mortality rate in females would have been reduced.
Factors influencing increased in-hospital mortality in females observed in international studies may or may not be similar in our country. So, in the present study, In-hospital mortality rate between male and female patients with AMI was compared. In addition, factors influencing thegender-based in-hospital mortality differencewere assessed.
Aims and objectives:
General objective of this study was to compare the inhospital mortality between male and female patients with AMI. Specific objectives were to identify the influencing factors of in-hospital mortality in patients with AMI, to compare these between male and female patients and their role in predictingender-based mortality difference.
Patients and methods:
This prospective observational study was done in the department of Cardiology, National Institute of Cardiovascular Diseases (NICVD), Dhaka, Bangladesh during the period from January 2008 -December 2008. Total 200 nonrandomisedpatients with a definite diagnosis of AMI were enrolled in the study, in which 100 female patients were considered as cases and 100 male patients as controls. AMI patients presenting first time in the hospital within 24 hours of symptom onset were included in this study. AMI patients admitted after 24 hours of symptom onset and those with associated prior myocardial infarction, prior percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) were excluded from the study. AMI was diagnosed according to Universal definition criteria 4 :Detection of rise and or fall of cardiac biomarkers (preferably troponin) with at least one value above the 99 th percentile of the upper reference limit (URL) together with evidence of myocardial ischemia with at least one of the following: 1)symptoms of ischemia 2)ECG changes indicative of new ischemia [new ST-T changes or new left bundle branch block (LBBB)] 3)development of pathological Q waves in the ECG 4) imaging evidence of new loss of viable myocardial or new regional wall motion abnormality. In our laboratory setting, cut off value of Troponin I was 0.49 nanogram per milliliter (ng/mL). 
Results:
Age distribution of the study population is shown in table I. Most of the patients were in 41-60 years age range in both groups (females 63% vs males 67%). Mean age was found 57.0±10.1 in females and 53.3±10.3 years in male (p=0.029).
Females and males were different in major risk factor profile which is shown in table II. Diabetes Mellitus(DM), Hypertension (HTN), smoking and Dyslipidemia were 39% vs 24%, 42% vs 39%, 4% vs 59%, and 45% vs 32% in females and males respectively. Differences were statistically significant in terms of DM, smoking and dyslipidemia (p<0.05) but not in HTN.
Prehospital delay was more in female patients than males (72% vs 58%, p=0.038) as shown in table III.
Streptokinase and beta blockers were also underused in females compared to males (15.6% vs32.2%, p=0.011 and 63% vs 75%, p=0.046 respectively) which are shown in tables IV and V. Table VI shows that there was significant higher in-hospital mortality in females in comparison to males (21% vs 10%, p=0.032). Table VII shows complications which reveals that Congestive heart failure, Unstable angina and re-infarction were more in females than males though the differences are not significant statistically. 
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Discussion:
Alfredssonet al 2 mentioned that females sustaining AMI have a higher mortality than males. In Bangladesh perspective, we tried to explore in-hospital mortality difference between female and male patients with AMI and also to assess factors influencing this gender difference.In the present study, mean age of females was significantly higher than that of their male counterpart (57.0±10.1 years and 53.3±10.3 years respectively, p=0.029). Momenuzzaman 7 found a similar age distribution with respect to sex. The higher age incidence of ischemic heart diseases in female patients explains the fact that reproductive hormones before menopause offers protection against ischemic heart diseases, which is markedly reduced at menopause due to hormonal imbalance rendering them more vulnerable to ischaemic heart diseases 8 .Regarding risk factors,smoking was strikingly higher among males (59%) compared to the females (4%)(p<0.001). Similar smoking behaviour was observed in the studies conducted by others. 7,9,10 Diabetes mellitus was considerably higher in female patients (39%) than that in male patients (24%) which is consistent with Gottlieb et al 9 and Jiang et al 10 . Momenuzzaman 7 did not observe any sex differential in terms of diabetes mellitus, while Hanratty et al 11 found a low prevalence of diabetes mellitus in both sexes (female 16%vs male 11%).Regarding hypertension, no significant difference was observed between the groups (female 42%, male 39%, p=0.666) bearing consistency with findings of Momenuzzma 7 . However, the findings differ from those reported by Gottlieb et al 9 and Jiang et al 10 who found a significantly higher prevalence of hypertension in females compared to males.Females had a higher incidence of hyperlipidemia as opposed to males (45% vs 32%, p=0.040). Similar results were also reported by others. 9, 10, 12 Regarding treatment with reperfusion, in our series, we used Streptokinase for reperfusion therapy within 12 hours of symptom onset in cases of eligible STEMI patients. Streptokinase was significantly underused in females (15.6%) compared to males (32.2%) (p=0.011).Underuse of reperfusion therapy was also reported in other studies. 7, 10, 13 The underuse of reperfusion therapy in our female patients may be explained by higher frequency of prehospital delay (>12 hours) in females (72%) compared to their male counterpart (58%) (p=0.038). Nag et al 16 also explained delayed arrival as a cause of underuse of Streptokinase. Comparison of use ofâ-blockers showed it was underused in females (63%) compared to males (75%) which is statistically significant (p=0.046).This finding is consistent with previous reports. 9, 10, [12] [13] [14] [15] The significant underuse of â-blockers in female patients in our study may be explained by the fact that more females had diabetes mellitus and congestive heart failure. International data support the fact that despite recommendations in favour of use of â-blockers, these are still underused in post-infarct patients, at the expense of many lives lost 17 .
Primary endpoint of our study was in-hospital death and secondary endpoints were unstable angina pectoris (early post MI angina), re-infarction and congestive heart failure and arrhythmias. Our study results showed that despite all necessary treatments females had 21% in-hospital mortality compared to 10% in males. The difference is significant (p=0.032).Similar results were observed by Hossain et al 3 and others. 7, 10 Several other studies 11, 13, 14 conducted around different parts of the world also reported higher in-hospital mortality in females than in males.Analysisof complications showed that in our series, Killip class III or more of cardiac failure was found in 14% females and 7% males. Our findings are in accordance with those found byjiang et al 10 andVaccarinoet al 14 . These findings correlate with increased mortality in females, as Killip class of cardiac failure I through IV predicts hospital mortality by 6%,17%, 38% and 81% respectively 6 .
Study Limitation:
This study had several limitations. The followings deserve mention:
Firstly, the study sample was taken consecutively (nonrandomly) which might have affected the outcome of study.
Secondly, the sample size was relatively small as needed to predict the gender difference in mortality in patients of AMI.
Thirdly,risk factor profile is lacking in data of positive family history ofischaemic heart disease (IHD). Ambiguous history andlack of relevant documentary papers led us to this limitation.
Finally, the study did not have the scope to include the information of the patients of AMI who died on the way to reaching hospital, which might have resulted in an underestimation of the mortality rates in patients with AMI.
Conclusion:
From the findings of the study and discussion thereof it could obviously be concluded that females are more likely to die of acute myocardial infarction than males with same disease. Females are generally older than their male counterpart, arrive later in hospital after symptom onset and have higher Killip class (e"III) of cardiac failure. The study also reveals that females have a higher prevalence of major risk factors for ischemic heart diseases except smoking. Streptokinase and â-blockers are less used in females than in males. Recognizing the mortality difference between females and males with acute myocardial infarction is of paramount clinical significance, for females need optimal treatment like males.
